ARCHIVES

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

Study Finds Green Tea No Help In Advanced Prostate Cancer

March 28, 2003

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

August 3, 1990

House Members Who Voted for Veto

January 3, 1986

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

June 22, 2012

Research Opportunities Growing, $$ Shrinking, Young Tells Congress

March 29, 1991